IgG Subclasses and Allotypes: From Structure to Effector Functions
|
journal
|
October 2014 |
HLA‐selected platelets for platelet refractory patients with HLA antibodies: a single‐center experience
|
journal
|
December 2018 |
Genomewide association study of HLA alloimmunization in previously pregnant blood donors
|
journal
|
November 2017 |
CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
|
journal
|
February 1998 |
Frequency and causes of refractoriness in multiply transfused patients
|
journal
|
April 1997 |
Removal of HLA-A,B antigens from platelets
|
journal
|
February 1984 |
Platelet transfusion refractoriness caused by a mismatch in HLA‐C antigens
|
journal
|
March 2002 |
In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice
|
journal
|
December 2020 |
Dynamic Visualization of Thrombopoiesis Within Bone Marrow
|
journal
|
September 2007 |
HLA gene and haplotype frequencies in Dutch blood donors
|
journal
|
November 1996 |
Novel clearance mechanisms of platelets
|
journal
|
November 2010 |
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients
|
journal
|
May 2005 |
Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells
|
journal
|
November 2010 |
TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
|
journal
|
September 2014 |
A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen allo‐immunized patients
|
journal
|
February 2020 |
Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles
|
journal
|
May 2008 |
Platelet transfusion refractoriness and anti‐HLA immunization
|
journal
|
March 2021 |
The mean fluorescence intensities of anti‐HLA antibodies detected using micro‐bead flow cytometry predict the risk of platelet transfusion refractoriness
|
journal
|
May 2013 |
Physical Proximity and Functional Interplay of the Glycoprotein Ib-IX-V Complex and the Fc Receptor FcγRIIA on the Platelet Plasma Membrane
|
journal
|
February 1998 |
The HLA System: Genetics, Immunology, Clinical Testing, and Clinical Implications
|
journal
|
January 2007 |
Structural epitope matching for HLA‐alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support?
|
journal
|
November 2007 |
Proteomic study of apheresis platelets made HLA class I deficient for transfusion of refractory patients
|
journal
|
September 2021 |
T cell–mediated autoimmunity in immune thrombocytopenia
|
journal
|
September 2021 |
Scalable Generation of Universal Platelets from Human Induced Pluripotent Stem Cells
|
journal
|
November 2014 |
Platelet transfusion refractoriness
|
journal
|
July 2008 |
Leukocyte Reduction and Ultraviolet B Irradiation of Platelets to Prevent Alloimmunization and Refractoriness to Platelet Transfusions
|
journal
|
December 1997 |
Human platelet IgG Fc receptor FcγRIIA in immunity and thrombosis
|
journal
|
June 2015 |
Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations
|
journal
|
April 2017 |
HLA‐DR expression by platelets in acute idiopathic thrombocytopenic purpura
|
journal
|
August 1992 |
CD8+ T cells induce platelet clearance in the liver via platelet desialylation in immune thrombocytopenia
|
journal
|
June 2016 |
Recipient humoral immunity against leukoreduced allogeneic platelets is suppressed by aminoguanidine, a selective inhibitor of inducible nitric oxide synthase
|
journal
|
October 1996 |
Acid Elution of Platelets Hla‐Class i Antigens in the Treatment of a Refractory Patient
|
journal
|
January 1998 |
The consequences of recurrent genetic and epigenetic variants in human pluripotent stem cells
|
journal
|
December 2022 |
Unique processing pathways within recipient antigen-presenting cells determine IgG immunity against donor platelet MHC antigens
|
journal
|
March 2000 |
Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity
|
journal
|
October 2013 |
Platelet transfusion refractoriness: how do I diagnose and manage?
|
journal
|
December 2020 |
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
|
journal
|
April 2009 |
Understanding platelet generation from megakaryocytes: implications for in vitro–derived platelets
|
journal
|
March 2016 |
Adenosine Diphosphate (ADP) and ADP Receptor Play a Major Role in Platelet Activation/Aggregation Induced by Sera From Heparin-Induced Thrombocytopenia Patients
|
journal
|
January 1998 |
Platelet CD36 deficiency is present in 2.6% of Arabian individuals and can cause NAIT and platelet refractoriness
|
journal
|
April 2021 |
The clinical impact of platelet refractoriness: correlation with bleeding and survival
|
journal
|
September 2008 |
Platelets made HLA deficient by acid treatment aggregate normally and escape destruction by complement and phagocytes in the presence of HLA antibodies
|
journal
|
October 2015 |
Interaction of two GPIIb/IIIa monoclonal antibodies with platelet Fc receptor (FcγRII)
|
journal
|
May 1991 |
Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity
|
journal
|
May 1996 |
FcγRIIA requires a Gi-dependent pathway for an efficient stimulation of phosphoinositide 3-kinase, calcium mobilization, and platelet aggregation
|
journal
|
November 2000 |
IgG antiplatelet immunity is dependent on an early innate natural killer cell–derived interferon-γ response that is regulated by CD8+ T cells
|
journal
|
April 2004 |
A subset of anti-HLA antibodies induces FcγRIIa-dependent platelet activation
|
journal
|
June 2018 |
Safety, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Adult Patients with Primary Immune Thrombocytopenia: A Randomized, Double-Blind and Placebo-Controlled Phase 1b Study
|
journal
|
November 2021 |
Platelet FcγRIIA in immunity and thrombosis: Adaptive immunothrombosis
|
journal
|
May 2021 |
Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
|
journal
|
January 2015 |
Antigen-guided depletion of anti-HLA antibody–producing cells by HLA-Fc fusion proteins
|
journal
|
October 2022 |
Function of Acid‐Treated Platelets for Transfusion
|
journal
|
September 1992 |
Platelet Quality and Reduction of hla Expression in Acid‐Treated Platelet Concentrates
|
journal
|
March 1993 |
Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application
|
journal
|
January 2010 |
Crystal structure of the human leukocyte Fc receptor, FcγRIIa.
|
journal
|
May 1999 |
iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study
|
journal
|
December 2022 |
Structural Basis for FcγRIIa Recognition of Human IgG and Formation of Inflammatory Signaling Complexes
|
journal
|
August 2011 |
Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys
|
journal
|
July 2015 |
iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
|
journal
|
January 2020 |
Ex Vivo Large‐Scale Generation of Human Platelets from Cord Blood CD34 + Cells
|
journal
|
December 2006 |
Autoantibody-mediated desialylation impairs human thrombopoiesis and platelet lifespan
|
journal
|
December 2019 |
Platelets from donors with consistently low HLA-B8, -B12, or -B35 expression do not undergo antibody-mediated internalization
|
journal
|
January 2018 |
Platelet CD40L at the interface of adaptive immunity
|
journal
|
March 2011 |
An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial
|
journal
|
January 2021 |
Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness
|
journal
|
October 2020 |
Bleeding risk and platelet transfusion refractoriness in patients with acute myelogenous leukemia who undergo autologous stem cell transplantation
|
journal
|
July 2000 |
Genetic polymorphisms of human platelet antigens in Euro-African and Japanese descendants from Parana, Southern Brazil
|
journal
|
January 2017 |
Cleavage of anti-PF4/heparin IgG by a bacterial protease and potential benefit in heparin-induced thrombocytopenia
|
journal
|
May 2019 |
Variants of CD36 gene and their association with CD36 protein expression in platelets
|
journal
|
January 2014 |
Generation of functional platelets from human embryonic stem cells in vitro via ES-sacs, VEGF-promoted structures that concentrate hematopoietic progenitors
|
journal
|
June 2008 |
Pathophysiology of immune thrombocytopenia
|
journal
|
September 2018 |
Platelet FcγRIIA HIS131ARG polymorphism and platelet function: antibodies to platelet-bound fibrinogen induce platelet activation
|
journal
|
February 2003 |
An alloimmunized, thrombocytopenic patient successfully transfused with acid‐treated, random‐donor platelets
|
journal
|
November 1991 |
Frequency of CD36 deficiency in Thais analyzed by quantification of CD36 on cell surfaces and in plasma
|
journal
|
March 2020 |
HLA class I depletion by citric acid, and irradiation of apheresis platelets for transfusion of refractory patients
|
journal
|
February 2021 |
Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production
|
journal
|
July 2018 |
Generation and characterization of HLA-universal platelets derived from induced pluripotent stem cells
|
journal
|
May 2020 |
Polymorphisme des antigènes plaquettaires humains dans la population tunisienne : intérêt clinique et anthropologique
|
journal
|
November 2019 |
Treatment of Alloimmunized. Thrombocytopenic Patient with Acid‐Treated Random Donor Platelets
|
journal
|
May 1992 |
Distribution of CD36 deficiency in different Chinese ethnic groups
|
journal
|
July 2020 |
Humanized mouse models of FcR clearance in immune platelet disorders
|
journal
|
March 2002 |
Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets
|
journal
|
September 2018 |
Fc galactosylation of anti-platelet human IgG1 alloantibodies enhances complement activation on platelets
|
journal
|
March 2022 |
Generation of HLA‐deficient platelets from hematopoietic progenitor cells
|
journal
|
August 2010 |
Platelet transfusion refractoriness associated withHPA‐1a (PlA1) alloantibody without coexistent HLA antibodies successfully treated with antigen‐negative platelet transfusions
|
journal
|
August 2001 |
HLA class I‐eluted platelets as an alternative to HLA‐matched platelets
|
journal
|
May 1996 |
HLA-Mediated Platelet Refractoriness
|
journal
|
October 2018 |
Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution
|
journal
|
June 1999 |
Desialylation is a mechanism of Fc-independent platelet clearance and a therapeutic target in immune thrombocytopenia
|
journal
|
July 2015 |
CD8+ T cells mediate antibody-independent platelet clearance in mice
|
journal
|
April 2016 |
Alloantibodies and Platelets
|
book
|
January 2020 |
Anchoring IgG-degrading enzymes to the surface of platelets selectively neutralizes antiplatelet antibodies
|
journal
|
August 2022 |
Human platelet antigens – 2013
|
journal
|
September 2013 |